HRT Not Advised for Disease Prevention Post Menopause

Share this content:
HRT Not Advised for Disease Prevention Post Menopause
HRT Not Advised for Disease Prevention Post Menopause

WEDNESDAY, May 17, 2017 (HealthDay News) -- Using hormone therapy to prevent chronic health issues, such as cardiovascular disease and bone loss, in postmenopausal women may do more harm than good, the U.S. Preventive Services Task Force (USPSTF) says.

After reviewing current evidence, the Task Force has issued an updated draft recommendation, reaffirming its final statement issued in 2012. The expert panel advises against the use of hormones to prevent chronic conditions among postmenopausal women, including those who've had their uterus removed.

"It's important to note that this draft recommendation applies only to women who have gone through menopause and are considering hormone therapy to prevent chronic conditions," Task Force member Ann Kurth, Ph.D., of the Yale School of Nursing in New Haven, Conn., said in a USPSTF news release. "It does not apply to women who are considering hormone therapy to manage menopausal symptoms, such as hot flashes or night sweats."

The Task Force also said its recommendations don't apply to younger women who've gone through menopause earlier than usual. The recommendations also don't apply to younger women who have undergone surgical menopause. The panel's draft recommendation was posted on the Task Force's website. The public can comment on this draft until June 12.

Evidence Review
Draft Recommendation Statement
Comment on Recommendation

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Herbal and Dietary Supplements Are Commonly Mislabeled

Herbal and Dietary Supplements Are Commonly Mislabeled

Bodybuilding products have highest mislabeling rate; many mislabeled products tied to liver injury

Alcoholic Cirrhosis Linked to Increased Admissions, Costs

Alcoholic Cirrhosis Linked to Increased Admissions, Costs

Compared with non-alcoholic cirrhosis, excess 30-day readmissions total 29.2 per 100 patients

is free, fast, and customized just for you!

Already a member?

Sign In Now »